Edgewise Total Current Liabilities vs Total Liab Analysis
| EWTX Stock | USD 32.20 0.22 0.69% |
Edgewise Therapeutics financial indicator trend analysis is much more than just examining Edgewise Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Edgewise Therapeutics is a good investment. Please check the relationship between Edgewise Therapeutics Total Current Liabilities and its Total Liab accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edgewise Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Edgewise Stock please use our How to Invest in Edgewise Therapeutics guide.
Total Current Liabilities vs Total Liab
Total Current Liabilities vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Edgewise Therapeutics Total Current Liabilities account and Total Liab. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Edgewise Therapeutics' Total Current Liabilities and Total Liab is -0.25. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Liab in the same time period over historical financial statements of Edgewise Therapeutics, assuming nothing else is changed. The correlation between historical values of Edgewise Therapeutics' Total Current Liabilities and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Edgewise Therapeutics are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Total Current Liabilities i.e., Edgewise Therapeutics' Total Current Liabilities and Total Liab go up and down completely randomly.
Correlation Coefficient | -0.25 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Total Current Liabilities
Total Current Liabilities is an item on Edgewise Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Edgewise Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from Edgewise Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Edgewise Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edgewise Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Edgewise Stock please use our How to Invest in Edgewise Therapeutics guide.Selling General Administrative is likely to rise to about 24.6 M in 2024, despite the fact that Issuance Of Capital Stock is likely to grow to (527.2 K).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 402K | 4.0M | 14.2M | 14.9M | Net Interest Income | 402K | 4.0M | 14.2M | 14.9M |
Edgewise Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Edgewise Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Edgewise Stock Analysis
When running Edgewise Therapeutics' price analysis, check to measure Edgewise Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edgewise Therapeutics is operating at the current time. Most of Edgewise Therapeutics' value examination focuses on studying past and present price action to predict the probability of Edgewise Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edgewise Therapeutics' price. Additionally, you may evaluate how the addition of Edgewise Therapeutics to your portfolios can decrease your overall portfolio volatility.